• Citer

Everolimus plus exemestane in postmenopausal patients with HR+ breast cancer: BOLERO-2 final progression-free survival analysis

par Yardley, Denise;Burris, Howard H.A.;Noguchi, Shinzaburo;Pritchard, Kathleen;Baselga, José;Gnant, Michael;Hortobagyi, Gabriel N.;Campone, Mario;Pistilli, Barbara;Piccart-Gebhart, Martine ;Melichar, Bohuslav;Petrakova, Katarina;Arena, Francis F.P.;Erdkamp, Frans;Harb, Wael W.A.;Feng, Wentao;Cahana, Ayelet;Taran, Tetiana;Lebwohl, David;Rugo, Hope
Référence Advances in therapy, 30, 10, page (870-884)
Publication Publié, 2013-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Everolimus plus exemestane in postmenopausal patients with HR+ breast cancer: BOLERO-2 final progression-free survival analysis
Auteur:	Yardley, Denise; Burris, Howard H.A.; Noguchi, Shinzaburo; Pritchard, Kathleen; Baselga, José; Gnant, Michael; Hortobagyi, Gabriel N.; Campone, Mario; Pistilli, Barbara; Piccart-Gebhart, Martine; Melichar, Bohuslav; Petrakova, Katarina; Arena, Francis F.P.; Erdkamp, Frans; Harb, Wael W.A.; Feng, Wentao; Cahana, Ayelet; Taran, Tetiana; Lebwohl, David; Rugo, Hope
Informations sur la publication:	Advances in therapy, 30, 10, page (870-884)
Statut de publication:	Publié, 2013-10
Sujet CREF:	Sciences bio-médicales et agricoles
	Pharmacologie
Mots-clés:	Advanced breast cancer
	Everolimus
	Exemestane
	Hormone receptor positive
	Nonsteroidal aromatase inhibitors
	Oncology
	Postmenopausal
	Progression-free survival
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Androstadienes -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Bone Neoplasms -- drug therapy -- secondary
	Breast Neoplasms -- drug therapy -- metabolism -- pathology
	Disease-Free Survival
	Double-Blind Method
	Female
	Humans
	Liver Neoplasms -- drug therapy -- secondary
	Lung Neoplasms -- drug therapy -- secondary
	Middle Aged
	Postmenopause
	Receptors, Estrogen -- metabolism
	Receptors, Progesterone -- metabolism
	Sirolimus -- administration & dosage -- analogs & derivatives
	Treatment Outcome
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0741-238X
	info:doi/10.1007/s12325-013-0060-1
	info:scp/84889654398
	info:pmid/24158787
	PMC3898123